Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Internist (Berl) ; 62(5): 549-554, 2021 May.
Artículo en Alemán | MEDLINE | ID: mdl-33326044

RESUMEN

A 61-year-old female patient presented to the emergency room with nausea. Laboratory findings revealed metabolic acidosis, which had to be associated with a sodium-glucose co-transporter­2 (SGLT2) inhibitor. Due to increasing prescription rates of SGLT2 inhibitors for diabetes mellitus, congestive heart failure or chronic renal insufficiency, a growing numbers of cases of SGLT2 inhibitor-associated ketoacidosis should be expected. Calculating the anion gap can provide orientation in the case of acidosis of unknown origin. Presumably, a relevant proportion of such cases of ketoacidosis is currently being overlooked or its diagnosis delayed.


Asunto(s)
Diabetes Mellitus Tipo 2 , Cetoacidosis Diabética , Cetosis , Inhibidores del Cotransportador de Sodio-Glucosa 2 , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Cetoacidosis Diabética/inducido químicamente , Cetoacidosis Diabética/diagnóstico , Femenino , Humanos , Hipoglucemiantes , Cetosis/inducido químicamente , Cetosis/diagnóstico , Persona de Mediana Edad , Náusea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...